askvity

What is TdP in ECG?

Published in Electrocardiography 3 mins read

Torsades de pointes (TdP) in ECG is a specific type of ventricular tachycardia characterized by a twisting of the QRS complexes around the isoelectric baseline, giving it a spiral or "twisting around the points" appearance.

Here's a more detailed explanation:

Characteristics of Torsades de Pointes:

  • Ventricular Tachycardia: TdP is a fast heart rhythm originating in the ventricles (lower chambers of the heart).
  • Varying QRS Complex Amplitude: The QRS complexes (representing ventricular depolarization) change in amplitude and direction, seemingly twisting around the baseline. They appear first positive, then negative, and so on.
  • Prolonged QT Interval: TdP is typically associated with a prolonged QT interval on the ECG. The QT interval represents the time it takes for the ventricles to depolarize and repolarize. A prolonged QT interval indicates a delay in ventricular repolarization, which increases the susceptibility to TdP. This is often drug-induced.
  • Polymorphic: The morphology of the QRS complexes is polymorphic, meaning they vary in shape and size.
  • Sudden Onset and Termination: TdP can start and stop suddenly. It can be self-limiting, but it can also degenerate into ventricular fibrillation, which is life-threatening.

Why is TdP important?

TdP is a dangerous arrhythmia that can lead to:

  • Syncope (fainting): Due to reduced blood flow to the brain.
  • Cardiac Arrest: If TdP degenerates into ventricular fibrillation.
  • Sudden Death: Without prompt treatment.

Causes of TdP:

The most common cause of TdP is drug-induced QT prolongation. Many medications can prolong the QT interval, including:

  • Antiarrhythmics (e.g., sotalol, amiodarone)
  • Antipsychotics (e.g., haloperidol, quetiapine)
  • Antibiotics (e.g., macrolides, fluoroquinolones)
  • Antidepressants (e.g., tricyclic antidepressants, SSRIs)
  • Antiemetics (e.g., ondansetron)

Other causes of QT prolongation and TdP include:

  • Electrolyte imbalances: Hypokalemia (low potassium), hypomagnesemia (low magnesium), and hypocalcemia (low calcium).
  • Congenital Long QT Syndrome: A genetic condition that predisposes individuals to prolonged QT intervals and TdP.
  • Bradycardia (slow heart rate): Slow heart rates can prolong the QT interval.
  • Heart disease: Certain heart conditions can increase the risk of TdP.

Diagnosis and Treatment:

TdP is diagnosed based on the characteristic ECG findings described above. Treatment involves:

  • Immediate defibrillation: If the patient is unstable (e.g., unconscious, no pulse).
  • Magnesium sulfate: This is the first-line treatment for TdP, even if the patient has normal magnesium levels.
  • Discontinuation of offending medications: Stop any drugs that may be prolonging the QT interval.
  • Correction of electrolyte imbalances: Replace potassium, magnesium, and calcium as needed.
  • Increasing the heart rate: Temporary pacing or isoproterenol can be used to shorten the QT interval by increasing the heart rate.

In summary, Torsades de pointes is a life-threatening ventricular arrhythmia characterized by its unique twisting pattern on the ECG, typically associated with a prolonged QT interval and requiring immediate medical intervention.

Related Articles